These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32401064)

  • 1. CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.
    Xiang X; Qian K; Zhang Z; Lin F; Xie Y; Liu Y; Yang Z
    J Drug Target; 2020; 28(7-8):727-731. PubMed ID: 32401064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection.
    Hillary VE; Ignacimuthu S; Ceasar SA
    Expert Rev Mol Diagn; 2021 Nov; 21(11):1179-1189. PubMed ID: 34409907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolstering Africa's coronavirus detection efforts.
    Tsanni A
    Nature; 2020 Jun; 582(7810):140. PubMed ID: 32494076
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19.
    Hou T; Zeng W; Yang M; Chen W; Ren L; Ai J; Wu J; Liao Y; Gou X; Li Y; Wang X; Su H; Gu B; Wang J; Xu T
    PLoS Pathog; 2020 Aug; 16(8):e1008705. PubMed ID: 32853291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast, portable tests come online to curb coronavirus pandemic.
    Sheridan C
    Nat Biotechnol; 2020 May; 38(5):515-518. PubMed ID: 32203294
    [No Abstract]   [Full Text] [Related]  

  • 7. New and developing diagnostic platforms for COVID-19: A systematic review.
    Chauhan N; Soni S; Gupta A; Jain U
    Expert Rev Mol Diagn; 2020 Sep; 20(9):971-983. PubMed ID: 32896179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19.
    Kashir J; Yaqinuddin A
    Med Hypotheses; 2020 Aug; 141():109786. PubMed ID: 32361529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas Biology and Its Application to Infectious Diseases.
    Strich JR; Chertow DS
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30429256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 Diagnostic Dilemma: a Clinician's Perspective.
    Rogers R; O'Brien T; Aridi J; Beckwith CG
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-based point-of-care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS-CoV-2 detection.
    Verma MK; Roychowdhury S; Sahu BD; Mishra A; Sethi KK
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23113. PubMed ID: 35642647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis for Covid-19: A mini-review.
    Pizzol JLD; Hora VPD; Reis AJ; Vianna J; Ramis I; Groll AV; Silva PAD
    Rev Soc Bras Med Trop; 2020; 53():e20200451. PubMed ID: 32876316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak.
    Binnicker MJ
    Clin Chem; 2020 May; 66(5):664-666. PubMed ID: 32077933
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR/Cas13: A potential therapeutic option of COVID-19.
    Lotfi M; Rezaei N
    Biomed Pharmacother; 2020 Nov; 131():110738. PubMed ID: 33152914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
    Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
    [No Abstract]   [Full Text] [Related]  

  • 16. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 spurs wave of innovative diagnostics.
    Sheridan C
    Nat Biotechnol; 2020 Jul; 38(7):769-772. PubMed ID: 32641849
    [No Abstract]   [Full Text] [Related]  

  • 18. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
    Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.